Skip to main content

SynaptiQ CDP-Choline

Boost

250 mg

Sustain

250 mg

Dual Action

Choline + Cytidine

Daily Use

No Cycling Required
The thinking person’s choline. CDP-Choline (cytidine 5’-diphosphocholine, also called citicoline) is a naturally occurring intermediate in the synthesis of phosphatidylcholine — the primary phospholipid of neuronal membranes. Unlike simple choline salts, CDP-Choline delivers two synergistic molecules: choline for acetylcholine synthesis and membrane construction, and cytidine which converts to uridine for additional neuroplastic benefits. This dual-action compound has been studied in over 11,000 patients across clinical trials, demonstrating benefits for memory, attention, and neuroprotection. As the daily baseline cholinergic in NTRPX Boost and Sustain, SynaptiQ CDP-Choline provides the foundation upon which acute stacks (Sprint’s Alpha-GPC + Huperzine A) can build.
CDP-Choline works through two parallel pathways — cholinergic enhancement and membrane phospholipid synthesis:

Pathway 1: Cholinergic Enhancement

Pathway 2: Membrane Phospholipid Synthesis (Kennedy Pathway)

Key Insight: Oral CDP-Choline bypasses the rate-limiting CCT step by providing pre-formed CDP-Choline that converts to both choline AND cytidine (→ uridine → UTP → CTP), supplying substrates from multiple angles.

Pathway 3: Cytidine → Uridine Conversion

This cytidine → uridine conversion is significant because uridine has independent neuroplastic effects:
Uridine EffectMechanismCognitive Relevance
↑ PhosphatidylcholineKennedy pathway substrateMembrane synthesis
↑ Synaptic proteinsGene expressionSynaptogenesis
↑ Neurite outgrowthP2Y receptorsNeuroplasticity
↑ Dopamine releaseD1/D2 modulationMotivation, reward

Complete Mechanism Summary

MechanismPathwayMagnitudeOutcome
ACh synthesisCholine → ACh★★★★★Memory, attention
PC synthesisKennedy pathway★★★★★Membrane integrity
Uridine effectsCytidine → Uridine★★★★☆Neuroplasticity
Dopamine modulationUridine → DA★★★☆☆Motivation
NeuroprotectionMultiple★★★★☆Brain health

Why CDP-Choline Over Other Choline Sources?

ADME Parameters

ParameterValueNotes
Bioavailability~90% (oral)Excellent absorption
MetabolismHydrolyzed → Choline + CytidineIn gut and liver
Choline Tmax2-3 hoursPeak choline levels
Cytidine Tmax1-2 hoursRapidly converted to uridine
Half-lifeBiphasic: 2-3h (initial), 56h (terminal)Long tissue retention
Brain uptakeCrosses BBB as choline + uridineBoth components enter CNS
ExcretionRenal + respiratory (as CO₂)Complete elimination

Absorption and Metabolism

Plasma Timeline

Biphasic Elimination

CDP-Choline has an unusual pharmacokinetic profile with two distinct half-lives:
PhaseHalf-LifeSignificance
Initial (α)2-3 hoursPlasma redistribution
Terminal (β)56 hoursTissue incorporation
Implication: Single daily dosing is effective because tissue levels remain stable even as plasma fluctuates.

Comparison with Alpha-GPC Kinetics

ParameterCDP-CholineAlpha-GPC
Choline Tmax2-3 hours1-2 hours
Peak magnitudeModerateHigh
DurationProlongedShorter
Additional benefitsUridine/cytidineNone
Best forDaily baselineAcute performance

CDP-Choline (Citicoline) vs Other Choline Forms

FormCholine ContentBrain UptakeAdditional BenefitsBest Application
CDP-Choline18.5%★★★★☆ HighCytidine → UridineDaily cognitive
Alpha-GPC40%★★★★★ HighestNoneAcute performance
Choline Bitartrate41%★★☆☆☆ LowNoneBasic supplementation
Phosphatidylcholine13%★★★☆☆ ModeratePhospholipidLiver, membrane
Choline Chloride75%★★☆☆☆ LowNoneIndustrial/animal

Why CDP-Choline for Daily Use

Quality Specifications (SynaptiQ)

AttributeSpecificationMethod
IdentityCytidine 5’-diphosphocholineHPLC, NMR
Assay≥98.0%HPLC
Water content≤5.0%Karl Fischer
Heavy metals≤10 ppmICP-MS
Lead≤1 ppmICP-MS
Arsenic≤1 ppmICP-MS
Microbial (TPC)≤1000 CFU/gUSP <61>
Residual solventsPer ICH Q3CGC

Cognizin® vs Generic CDP-Choline

ParameterCognizin®Generic
Purity≥99%Variable (95-99%)
Clinical trialsMultiple (branded)Limited
ConsistencyBatch-to-batch verifiedVariable
CostHigherLower
RecommendationPreferred if availableAcceptable if tested
SynaptiQ Specification: NTRPX sources pharmaceutical-grade CDP-Choline meeting or exceeding Cognizin® standards. Each batch undergoes third-party testing for identity, purity, heavy metals, and microbial contamination. The 250mg dose in Boost and Sustain provides clinically-relevant choline and cytidine support for daily cognitive function.

Dose-Response Analysis

DoseCognitive EffectNeuroprotectionNotes
100 mgMinimalMinimalSubtherapeutic
250 mgModerateModerateNTRPX Boost/Sustain dose
500 mgGoodGoodCommon clinical dose
1000 mgStrongStrongUpper range; stroke trials
2000 mgStrongStrongAcute brain injury trials

NTRPX Protocol

ProductCDP-Choline DosePurposeTiming
Boost250 mgDaily foundationMorning
Sustain250 mgAfternoon maintenanceAfternoon
Combined500 mgFull daily coverageAM + PM

Clinical Trial Dosing

StudyPopulationDoseDurationFinding
Alvarez 1997Healthy elderly500 mg28 days↑ Memory
Spiers 1996Age-related memory1000 mg3 months↑ Verbal memory
McGlade 2012Healthy adults250-500 mg28 days↑ Attention, ↓ impulsivity
Bruce 2014Healthy women250-500 mg28 days↑ Attention
ICTUS TrialStroke2000 mg6 weeksNeuroprotection trend

Timing Optimization

Population-Specific Dosing

PopulationDoseFrequencyNotes
Healthy adults250-500 mgDailyCognitive maintenance
Cognitive decline500-1000 mgDailyHigher therapeutic range
Students/Professionals250-500 mgDailyFocus, memory support
Elderly500-1000 mgDailyNeuroprotection emphasis
Athletes250-500 mgDailyCholinergic support
With Sprint stack250 mgMorning (Boost)Baseline before acute

Why Split Dosing (Boost + Sustain)

FactorSingle 500mg AMSplit 250mg + 250mg
Plasma stabilityPeaks then dropsMore consistent
Afternoon coverageDiminishedMaintained
GI toleranceGoodBetter
FlexibilityLessMore
NTRPX approachPreferred

NTRPX System Synergies

CDP-Choline forms the cholinergic baseline upon which other NTRPX ingredients build:

Clinically-Proven Synergies

CombinationEvidence LevelMechanismOutcome
CDP-Choline + Alpha-GPCModerate (logical)Baseline + acute surgeEnhanced cholinergic range
CDP-Choline + Huperzine AModerate↑ ACh synthesis + ↓ ACh breakdownAmplified ACh signaling
CDP-Choline + Uridine + DHAStrong (Wurtman)Full Kennedy pathway supportSynaptogenesis ↑↑
CDP-Choline + PiracetamStrong (clinical)Cholinergic + racetamEnhanced memory
CDP-Choline + MemantineModerate (clinical)Cholinergic + NMDA modulationDementia adjunct

The Sprint Cholinergic Cascade

This is the core NTRPX cholinergic synergy:Why This Works:
  1. CDP-Choline (daily): Establishes baseline ACh and membrane support
  2. Alpha-GPC (acute): Rapid, high-magnitude ACh surge
  3. Huperzine A (acute): Prevents ACh breakdown, extends surge

The Wurtman Stack (Uridine + DHA + Choline)

Dr. Richard Wurtman at MIT demonstrated powerful synergy between uridine, DHA, and choline for synaptogenesis:
ComponentDoseCDP-Choline Provides
Uridine150-300 mg✓ Via cytidine conversion
DHA500-1000 mg✗ Add separately
Choline250-500 mg✓ Direct provision

Synergies with Other NTRPX Ingredients

NTRPX IngredientProductSynergy TypeMechanism
Alpha-GPCSprintAmplifyingBaseline + acute surge
Huperzine ASprintAmplifyingSynthesis + preservation
ParaxanthineParaCaffeineComplementaryCholinergic + adenosinergic
L-TheanineLunaComplementaryACh + alpha waves
MagnesiumLuna/BoostSupportiveNMDA modulation + cholinergic
GlycineLunaSupportiveNMDA glycine site + cholinergic
CreatineFutureSupportiveATP for ACh synthesis

Paraxanthine + CDP-Choline

Dual-pathway cognitive enhancement:

L-Theanine + CDP-Choline

Calm focus with cholinergic support:
CDP-Choline ContributionL-Theanine ContributionCombined
ACh ↑ for memoryAlpha waves for calmFocused learning
Membrane supportGlutamate modulationNeuroprotection
Sustained effectSustained effectAll-day coverage

Logical/Theoretical Synergies

CombinationRationaleTheoretical Benefit
CDP-Choline + BacopaACh + antioxidant + memory consolidationEnhanced long-term memory
CDP-Choline + Lion’s ManeACh + NGF supportNeuroplasticity + cholinergic
CDP-Choline + PhosphatidylserineTwo membrane phospholipidsComprehensive membrane support
CDP-Choline + B-vitaminsMethylation supportSAMe cycle support
CDP-Choline + RacetamsClassic stackEnhanced racetam response

Contraindicated Combinations

CombinationIssueRecommendation
CDP-Choline + High-dose Alpha-GPC dailyExcessive choline; possible TMAOUse Alpha-GPC acutely only
CDP-Choline + AnticholinergicsOpposing mechanismsAvoid or separate
CDP-Choline + AChE inhibitor drugsExcessive cholinergic activityMedical supervision only

Synergy Summary Table

SynergyNTRPX ProductsEvidenceRating
CDP-Choline + Alpha-GPC + Huperzine ABoost/Sustain + SprintLogical (strong)★★★★★
CDP-Choline + ParaxanthineBoost + ParaCaffeineLogical★★★★☆
CDP-Choline + L-Theanine + MgBoost + LunaLogical★★★★☆
CDP-Choline + Uridine + DHABoost + ExternalClinical (Wurtman)★★★★★
CDP-Choline + CreatineBoost + FutureLogical★★★★☆
NTRPX Synergy Philosophy: CDP-Choline serves as the daily cholinergic foundation across Boost and Sustain. It establishes baseline acetylcholine levels and membrane support that acute stacks (Sprint) can amplify. This “baseline + acute” model is central to NTRPX’s approach — sustainable daily support with on-demand enhancement.

Healthy Adult Cognition

StudyDesignNDoseDurationFinding
McGlade 2012RCT60250-500 mg28 days↑ Attention, ↓ impulsivity (CPT)
Bruce 2014RCT60250-500 mg28 days↑ Attention (healthy women)
Knott 2015RCT24500 mgAcute↑ Attention (ERP changes)
Alvarez 1997RCT24500 mg28 days↑ Memory (elderly healthy)
StudyDesignNDoseDurationFinding
Spiers 1996RCT951000 mg3 months↑ Verbal memory
Cacabelos 1996Open20671000 mgVariable↑ MMSE, attention, memory
Fioravanti 2005Cochrane Review14 trialsVariousVariousPositive effects on memory, behavior

Stroke and Brain Injury

StudyDesignNDoseDurationFinding
ICTUS 2012RCT22982000 mg6 weeksNon-significant trend toward benefit
Davalos 2002Meta-analysis1372VariousVariousImproved recovery outcomes
Saver 2010Meta-analysis4 trialsVariousVariousFavorable outcomes

Mechanism Studies

StudyFocusFinding
Wurtman 2000Uridine effects↑ Phosphatidylcholine synthesis
Secades 2006Comprehensive reviewMultiple neuroprotective mechanisms
Adibhatla 2002Membrane repair↑ Phospholipid synthesis post-injury

Effect Size Summary

OutcomeEffect SizeEvidence Level
Attention (healthy)d = 0.3-0.5Moderate-High
Memory (elderly)d = 0.4-0.6Moderate
Verbal fluencyd = 0.3-0.4Moderate
Global cognition (impaired)VariableModerate
Stroke recoveryModestModerate

Total Clinical Evidence Base

MetricValue
Total patients studied>11,000
Randomized controlled trials50+
Systematic reviews5+
Countries studied in20+
Decades of research4+

References

Healthy Cognition:
  • McGlade E et al. Improved attentional performance following citicoline administration. Food Nutr Sci. 2012;3(6):769-73.
  • Bruce SE et al. Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage. Int J Food Sci Nutr. 2014;65(8):1003-7. PubMed
Age-Related Decline:
  • Spiers PA et al. Citicoline improves verbal memory in aging. Arch Neurol. 1996;53(5):441-8. PubMed
  • Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances. Cochrane Database Syst Rev. 2005;(2):CD000269. PubMed
Stroke:
  • Davalos A et al. Citicoline in the treatment of acute ischaemic stroke. Lancet. 2012;380(9839):349-57. PubMed
Mechanism:
  • Wurtman RJ et al. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol. 2000;60(7):989-92. PubMed
  • Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol. 2006;28(Suppl B):1-56. PubMed

Adverse Event Profile

EventIncidenceSeverityNotes
Headache2-5%MildUsually transient
GI upset2-3%MildNausea, diarrhea
Insomnia1-2%MildIf taken late; avoid evening
Restlessness<1%MildRare; dose-related

Safety Data

ParameterFinding
LD50 (rat, oral)>4,000 mg/kg
NOAEL1,000 mg/kg/day (rat, 6 months)
Maximum studied (acute stroke)4,000 mg/day
Chronic studied dose2,000 mg/day for months
GenotoxicityNegative
CarcinogenicityNo evidence
TeratogenicityNo evidence

Regulatory Status

RegionStatusNotes
United StatesGRAS; Dietary supplementFDA no objection to GRAS
European UnionMedical food / SupplementSome countries Rx, some OTC
JapanApproved drugPrescription for stroke
CanadaNHPLicensed products
AustraliaComplementary medicineTGA listed

Contraindications

CategoryConsiderationSeverity
None absoluteVery safe profile
AChE inhibitor drugsAdditive cholinergic effect★★★☆☆ Medical supervision
Parkinson’s medsTheoretical interaction★★☆☆☆ Consult provider

Drug Interactions

Drug ClassInteractionSeverityNotes
AChE inhibitors (Aricept, etc.)Additive ACh effect★★★☆☆Often used together under supervision
AnticholinergicsOpposing effects★★☆☆☆May reduce benefit
LevodopaTheoretical potentiation★★☆☆☆Monitor
MeclizineAnticholinergic opposition★★☆☆☆May reduce benefit

Long-Term Safety

ParameterFinding
Chronic use (months-years)Well-tolerated
ToleranceNot observed
DependenceNone
WithdrawalNone
AccumulationNone with normal dosing

Special Populations

PopulationSafety StatusNotes
Healthy adultsExcellentPrimary market
ElderlyExcellentExtensively studied
Stroke patientsGoodHigh-dose trials
PregnancyLimited dataAvoid unless prescribed
ChildrenLimited dataNot typically recommended

Tier 1: Foundation

Efficacy

Moderate-High

Validation

Very High — 11,000+ patients; 50+ RCTs

Safety

Excellent — GRAS; decades of use
Tier Rationale: Tier 1 (Foundation) classification. CDP-Choline is one of the most extensively researched nootropic compounds with over 11,000 patients across 50+ clinical trials. Its dual mechanism (choline + cytidine/uridine) provides both cholinergic support and membrane synthesis benefits. Effect sizes are moderate but consistent. Safety profile is excellent with GRAS status and decades of human use. As the daily cholinergic foundation in NTRPX Boost and Sustain, CDP-Choline establishes the baseline upon which acute performance stacks can build.

Phosphatidylcholine: The Target Molecule

Phosphatidylcholine (PC) is the most abundant phospholipid in eukaryotic membranes:

Complete Kennedy Pathway

Rate-Limiting Step: CCT Enzyme

ParameterCCT Enzyme
Full nameCTP:phosphocholine cytidylyltransferase
RoleConverts phosphocholine → CDP-choline
Rate-limiting?Yes — controls PC synthesis rate
RegulationMembrane translocation, phosphorylation
CTP requirementRequires CTP (from UTP → CTP)
Why CDP-Choline Supplementation Works:
  1. Provides choline: Substrate for phosphocholine
  2. Provides cytidine → uridine → UTP → CTP: Substrate for CCT
  3. Effectively bypasses the rate-limit by supplying both substrates

Membrane Composition

Phospholipid% of Neural MembraneRole
Phosphatidylcholine (PC)40-50%Primary structural
Phosphatidylethanolamine (PE)20-30%Inner leaflet
Phosphatidylserine (PS)5-10%Signaling
Sphingomyelin5-10%Raft formation
Phosphatidylinositol (PI)2-5%Signaling

DHA Integration

The fatty acid composition of PC matters — DHA-enriched PC is particularly important for neural function:This is why CDP-Choline + DHA (Wurtman stack) is so powerful — CDP-Choline provides the choline and cytidine, while DHA provides the optimal fatty acid for neural PC.

Head-to-Head Analysis

ParameterCDP-CholineAlpha-GPC
Choline content18.5%40%
Choline deliveryModerate, sustainedHigh, rapid
Additional benefitsCytidine → UridineNone
Mechanism breadthDual pathwaySingle pathway
Peak effect2-3 hours1-2 hours
DurationProlonged (56h terminal)Shorter
Best applicationDaily baselineAcute performance
TMAO concernLower (less choline)Higher (more choline)
GH releaseMinimalDocumented
Clinical trialsExtensive (11,000+)Moderate
NTRPX roleBoost/Sustain (daily)Sprint (acute)

Complementary Use: The NTRPX Model

Why Not Just Use Alpha-GPC Daily?

ConcernAlpha-GPC DailyCDP-Choline Daily
TMAO productionHigher (more choline)Lower
Receptor downregulationPossible with chronic high AChLess likely
CostHigher per dayLower
Breadth of benefitCholine onlyCholine + Uridine
Sustained effectLessMore (long terminal half-life)

Summary: Use Both, Use Differently

CompoundWhenProductPurpose
CDP-CholineDailyBoost, SustainBaseline, membrane, uridine
Alpha-GPCAcute (2-3×/week)SprintPeak performance surge

When to Take CDP-Choline

GoalTimingDoseProduct
Daily cognitive supportMorning250 mgBoost
Extended daily supportMorning + afternoon250 mg × 2Boost + Sustain
Pre-learning/study1-2 hours before250-500 mgBoost
Before Sprint stackMorning (baseline)250 mgBoost

What to Expect

TimeframeExpected Response
Acute (first dose)Subtle; some report mild clarity
1-2 weeksImproved attention, verbal fluency
4+ weeksCumulative memory benefits
ChronicMaintained cognitive support

Signs It’s Working

DomainPositive Indicators
AttentionEasier focus, less distraction
MemoryBetter recall, verbal fluency
Mental clarityReduced brain fog
LearningInformation retention

Optimizing Response

FactorOptimization
ConsistencyDaily use for cumulative benefit
TimingMorning/afternoon; avoid late evening
StackingCombine with DHA for Wurtman synergy
Acute boostAdd Sprint for peak demands
CofactorsB-vitamins support methylation

Common Questions

Q: How is this different from eating eggs? A: Eggs provide choline (primarily as phosphatidylcholine), but CDP-Choline provides choline PLUS cytidine for uridine benefits. CDP-Choline also bypasses digestion of phospholipids.Q: Can I take CDP-Choline and Alpha-GPC together? A: Yes, but use CDP-Choline daily and Alpha-GPC acutely (Sprint days). Daily high-dose Alpha-GPC may increase TMAO.Q: Will CDP-Choline keep me awake? A: It’s mildly activating. Take in morning/afternoon, not evening.Q: How long until I notice effects? A: Subtle effects may be noticed within days; full benefits develop over 2-4 weeks of consistent use.Q: Is it safe long-term? A: Yes. CDP-Choline has been used chronically in clinical trials and medical practice for decades with excellent safety.

SynaptiQ Summary: CDP-Choline (250mg in Boost and Sustain) is the daily cholinergic foundation of the NTRPX system. Unlike simple choline salts, it delivers dual benefits: choline for acetylcholine synthesis and membrane construction, plus cytidine that converts to uridine for neuroplastic support. With over 11,000 patients studied across 50+ clinical trials, CDP-Choline provides well-validated cognitive support with an excellent safety profile. Use daily as baseline; amplify with Sprint (Alpha-GPC + Huperzine A) for acute demands.